Company Filing History:
6 out of 7 
2 out of 25 
1 out of 12 Years Active: 2017-2025
Title: Inventor Jongun Cho: Pioneering Advances in Antibody-Drug Conjugates and Benzodiazepine Derivatives
Introduction
Jongun Cho is a prominent inventor based in Daejeon, South Korea, known for his significant contributions to the field of biomedical innovations. With a total of six patents to his name, he has focused on developing advanced therapeutic agents, particularly in cancer treatment and longevity.
Latest Patents
Among his latest innovations is the patent for "Antibody-drug conjugates comprising anti-B7-H3 antibodies." This patent revolves around the development of antibody-drug conjugates (ADCs) that feature one or more active agents linked to an anti-B7-H3 antibody via a specialized linker. The patent emphasizes creating monoclonal antibodies and various forms that selectively bind to B7-H3, with potential applications spanning therapeutic, diagnostic, and prophylactic uses. Additionally, Cho has developed patentable "Benzodiazepine derivatives and uses thereof," which involves compounds and methods that may extend lifespan, showcasing his versatility in novel compound development.
Career Highlights
Jongun Cho has made his mark in the biopharmaceutical community, particularly through his work at renowned companies including Intocell, Inc. and Legochem Biosciences, Inc. His expertise in creating targeted therapeutic approaches has been recognized and applied in innovative treatment solutions, establishing him as a valuable contributor to the sector.
Collaborations
Throughout his career, Jongun Cho has collaborated with esteemed colleagues such as Taekyo Park and Sunyoung Kim. These partnerships underline the collaborative spirit within research institutions, fueling advancements in scientific discoveries and potentially leading to groundbreaking therapeutics.
Conclusion
In summary, Jongun Cho's impressive portfolio of patents and collaborative endeavors in Daejeon has established him as an influential inventor in the biomedical field. His innovative approaches to antibody-drug conjugates and life-extending compounds continue to inspire the next wave of research and development in medicine.